Cargando…

Association between plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and risk of Alzheimer's disease, metabolic syndrome, and female infertility: A meta-analysis

BACKGROUND: Plasminogen activator inhibitor-1 (PAI-1) is considered to be involved in the physiopathological mechanisms of Alzheimer's disease (AD), metabolic syndrome (MetS), and female infertility. Previous studies investigating the association between PAI-14G/5G (rs1799889) gene polymorphism...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xin, Gao, Bai, Xu, Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	5300
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738113/ https://www.ncbi.nlm.nih.gov/pubmed/33327353 http://dx.doi.org/10.1097/MD.0000000000023660

Ejemplares similares

Role of 4G/5G plasminogen activator inhibitor-1 (PAI-1) gene polymorphism and the PAI-1 plasma levels in the outcome of patients with severe sepsis
por: Lorente, L, et al.
Publicado: (2009)

Association of transferrin G258A and transferrin receptor A82G polymorphisms with the risk of Parkinson disease in certain area
por: Wang, Yan, et al.
Publicado: (2020)

Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study
por: Yousef, Aly A, et al.
Publicado: (2020)

Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study [Corrigendum]
Publicado: (2021)

Association of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene -675 4G/5G and -844 A/G Promoter Polymorphism with Risk of Keloid in a Chinese Han Population
por: Wang, Yongjie, et al.
Publicado: (2014)

Plasminogen activator inhibitor-1 (PAI-1) expression in endometriosis
por: Alotaibi, Fahad T., et al.
Publicado: (2019)

Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with metabolic syndrome parameters in Malaysian subjects
por: Al-Hamodi, Zaid H., et al.
Publicado: (2012)

The Synergistic Effect of Plasminogen Activator Inhibitor-1 (PAI-1) Polymorphisms and Metabolic Syndrome on Coronary Artery Disease in the Korean Population
por: Park, Han Sung, et al.
Publicado: (2020)

Dramatic thrombolysis after rapid injection of tissue plasminogen activator: A case report
por: Park, Jin-Sung, et al.
Publicado: (2019)

Rare severe hypofibrinogenemia induced by tissue plasminogen activator in stroke patients: Case report
por: Huang, Xuming, et al.
Publicado: (2021)

The −675 4G/5G Polymorphism in Plasminogen Activator Inhibitor-1 Gene Is Associated with Risk of Asthma: A Meta-Analysis
por: Nie, Wei, et al.
Publicado: (2012)

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas.
por: Bouchet, C., et al.
Publicado: (1994)

Relationship between plasminogen activator inhibitor type-1 (PAI-1) gene polymorphisms and osteoporosis in Turkish women
por: Ozgen, Merih, et al.
Publicado: (2012)

The 4G/4G Genotype of PAI-1 Polymorphism Is Associated with Higher Plasma PAI-1 Concentrations and Mortality in Patients with Severe Sepsis
por: Lorente, Leonardo, et al.
Publicado: (2015)

Clinical safety and outcome of recombinant tissue plasminogen activator in patients with stroke attributable to small artery occlusion: A protocol for systematic review and meta-analysis
por: Ni, Li-Yan, et al.
Publicado: (2021)

Genetics of Plasminogen Activator Inhibitor-1 (PAI-1) in a Ghanaian Population
por: White, Marquitta J., et al.
Publicado: (2015)

PAI-1, the Plasminogen System, and Skeletal Muscle
por: Rahman, Fasih Ahmad, et al.
Publicado: (2020)

The G41D mutation in SOD1-related amyotrophic lateral sclerosis exhibits phenotypic heterogeneity among individuals: A case report and literature review
por: Zhao, Xinyi, et al.
Publicado: (2022)

Monoclonal gammopathy of undeterminated significance and endoneurial IgG deposition: A case report
por: Mathis, Stéphane, et al.
Publicado: (2016)

Association between Five Common Plasminogen Activator Inhibitor-1 (PAI-1) Gene Polymorphisms and Colorectal Cancer Susceptibility
por: Oh, Jisu, et al.
Publicado: (2020)

Plasminogen activator inhibitor-1 4G/5G gene polymorphism and primary open-angle glaucoma
por: Mossböck, Georg, et al.
Publicado: (2008)

The 4G/5G polymorphism of plasminogen activator inhibitor type 1 is a predictor of allergic cough
por: Tang, Rui, et al.
Publicado: (2023)

PAI-1 4G/5G Polymorphism Contributes to Cancer Susceptibility: Evidence from Meta-Analysis
por: Wang, Shangqian, et al.
Publicado: (2013)

The Association Between Genetic Polymorphism rs703842 in CYP27B1 and Multiple Sclerosis: A Meta-Analysis
por: Jiang, Tao, et al.
Publicado: (2016)

Association between Plasminogen Activator Inhibitor-1 -675 4G/5G Polymorphism and Sepsis: A Meta-Analysis
por: Li, Li, et al.
Publicado: (2013)

Meta-Analysis of the Association between Plasminogen Activator Inhibitor-1 4G/5G Polymorphism and Recurrent Pregnancy Loss
por: Li, Xuejiao, et al.
Publicado: (2015)

Brain Metabolism of Less-Educated Patients With Alzheimer Dementia Studied by Positron Emission Tomography
por: Huang, Yu Ching, et al.
Publicado: (2015)

Association of Polymorphisms in Plasminogen Activator Inhibitor-1 (PAI-1), Tissue Plasminogen Activator (tPA), and Renin (REN) with Recurrent Pregnancy Loss in Korean Women
por: Cho, Hee Young, et al.
Publicado: (2021)

Plasminogen Activator Inhibitor-1 (PAI-1) deficiency predisposes to depression and resistance to treatments
por: Party, Hélène, et al.
Publicado: (2019)

SORL1 mutations are associated with parkinsonian and psychiatric features in Alzheimer disease: Case reports
por: Qiu, Guozhen, et al.
Publicado: (2021)

The role of tonifying kidney decoction and acupuncture in the treatment of Alzheimer’s disease: A network meta-analysis
por: Wang, Xin-Chen, et al.
Publicado: (2022)

The Role of TPA I/D and PAI-1 4G/5G Polymorphisms in Multiple Sclerosis
por: Živković, Maja, et al.
Publicado: (2014)

Relationship between post-SARS osteonecrosis and PAI-1 4G/5G gene polymorphisms
por: Sun, Wei, et al.
Publicado: (2013)

Clinical impact of the PAI-1 4G/5G polymorphism in Chinese patients with venous thromboembolism
por: Wang, Ziran, et al.
Publicado: (2022)

Plasminogen Activator Inhibitor-1 4G/5G Polymorphism Presenting as Recurrent Ischemic Stroke: The Microthrombi Shower
por: Dayco, John, et al.
Publicado: (2022)

Association of Plasminogen Activator Inhibitor-1 (PAI-1) Gene Polymorphisms with Osteoporotic Vertebral Compression Fractures (OVCFs) in Postmenopausal Women
por: Kim, Jung Oh, et al.
Publicado: (2016)

STK39, But Not BST1, HLA-DQB1, and SPPL2B Polymorphism, Is Associated With Han-Chinese Parkinson's Disease in Taiwan
por: Chang, Kuo-Hsuan, et al.
Publicado: (2015)

Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis
por: Zhang, Tengyue, et al.
Publicado: (2013)

Clinical and biological significance of RNA N6-methyladenosine regulators in Alzheimer disease
por: Qiu, Zhiqiang, et al.
Publicado: (2023)

The CYP19A1 rs3751592 variant confers susceptibility to Alzheimer disease in the Chinese Han population
por: Zheng, Jiaqiang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9saci36upjpsvjhcvn1ov3j039